GlobeMed Pharma Group is a Swiss-based pharmaceutical manufacturer specializing in the development and large-scale production of premium plant-derived cannabinoid APIs and isolates.
Our production facilities operate under EU-GMP and Swiss-GMP certification, with every batch verified through accredited third-party laboratories to ensure purity, consistency, and traceability. We maintain full compliance with the European Pharmacopoeia, Swissmedic, and EMA standards, supported by seed-to-sale transparency and meticulous process documentation at every stage.
Our vertically integrated operations combine advanced extraction science, validated process control, and ESG-aligned sourcing, ensuring that every product meets the highest standards of quality and environmental responsibility.